MedTrace Logo

The Role of hCG in Thawed Embryo Transfer

NCT07004192 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-07-01

No results posted yet for this study

Summary

This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

Conditions

  • Infertility (IVF Patients)

Interventions

DRUG

HCG injection

5000 IU hCG injection

OTHER

No intervention

No hCG administered in this group.

Sponsors & Collaborators

  • Fertility Center of Las Vegas

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-02
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07004192 on ClinicalTrials.gov